Patents by Inventor Friedrich Kremer

Friedrich Kremer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use
    Publication number: 20090239295
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Application
    Filed: May 28, 2009
    Publication date: September 24, 2009
    Inventors: Bernd Karl Friedrich Kremer, Fred Fandrich, Maren nee Schulze Ruhnke
  • Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use
    Publication number: 20090233363
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Application
    Filed: May 28, 2009
    Publication date: September 17, 2009
    Inventors: Bernd Karl Friedrich Kremer, Fred Fandrich, Maren nee Schulze Ruhnke
  • Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
    Patent number: 7553663
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Grant
    Filed: May 26, 2005
    Date of Patent: June 30, 2009
    Assignee: Blasticon Biotechnologische Forschung GmbH
    Inventors: Bernd Karl Friedrich Kremer, Fred Fändrich, Maren née Schulze Ruhnke
  • Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
    Patent number: 7553660
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Grant
    Filed: May 26, 2005
    Date of Patent: June 30, 2009
    Assignee: Blasticon Biotechnologische Forschung GmbH
    Inventors: Bernd Karl Friedrich Kremer, Fred Fändrich, Maren Ruhnke (née Schulze)
  • Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
    Patent number: 7517686
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Grant
    Filed: November 21, 2005
    Date of Patent: April 14, 2009
    Assignee: Blasticon Biotechnologische Forschung GmbH
    Inventors: Bernd Karl Friedrich Kremer, Fred Fändrich, Maren née Schulze Ruhnke
  • Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
    Patent number: 7138275
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Grant
    Filed: March 28, 2003
    Date of Patent: November 21, 2006
    Assignee: Blasticon Biotechnologische Forschung GmbH
    Inventors: Bernd Karl Friedrich Kremer, Fred Fändrich, Maren née Schulze Ruhnke
  • Method for determining at least one state parameter of a sealing system and sealing system
    Publication number: 20060220498
    Abstract: The invention relates to a method for determining at least one state parameter of a sealing system (10, 110) comprising at least one sealing element (12, 112) and at least one dielectric element (24, 124) containing dielectric material (26, 126). The invention is characterised in that the real part and/or the imaginary part of the complex, dielectric function of the dielectric element is measured.
    Type: Application
    Filed: February 5, 2004
    Publication date: October 5, 2006
    Applicant: UNIVERSITAET LEIPZIG
    Inventor: Friedrich Kremer
  • Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations
    Publication number: 20060188485
    Abstract: The invention relates to cells of monocytic origin suitable for the prevention and/or treatment of diseases associated with disturbed self-tolerance, in particular autoimmune diseases and allergies, and to pharmaceutical preparations containing these cells. The cells are autologous in relation to the patient to whom they are to be administered. The invention further relates to a process for the generation and/or, propagation of autologous regulatory T cells.
    Type: Application
    Filed: January 9, 2004
    Publication date: August 24, 2006
    Inventors: Bernd Karl Friedrich Kremer, Fred Fandrich, Maren Schulze
  • Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
    Publication number: 20040101962
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Application
    Filed: February 25, 2003
    Publication date: May 27, 2004
    Inventors: Bernd Karl Friedrich Kremer, Fred Fandrich, Maren nee Schulze Ruhnke
  • Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
    Publication number: 20040009595
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Application
    Filed: March 28, 2003
    Publication date: January 15, 2004
    Inventors: Bernd Karl Friedrich Kremer, Fred Faendrich, Maren nee Schulze Ruhnke